Atrial Fibrillation Trial, Recruiting NCT06984731 Sponsor: Affiliated Hospital of Nantong University Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06984731
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older and have been diagnosed with atrial fibrillation that is not caused by a heart valve problem
  • Your doctor has determined that you are a suitable candidate for both a left atrial appendage closure procedure (using the WATCHMAN FLX device) and a catheter-based procedure to treat atrial fibrillation
  • Scans taken before the procedure show that the shape and structure of your left atrial appendage are suitable for the WATCHMAN FLX device to be implanted
  • You are willing to take part in the study and have signed a consent form agreeing to participate

Who may not be able to join:

  • Your atrial fibrillation is caused by a heart valve problem or another structural heart condition
  • A blood clot was found in your heart, or you have had a recent clotting event, before the procedure
  • You have a serious tendency to bleed easily, or you have recently had a major bleeding event such as heavy gastrointestinal bleeding or bleeding in the brain
  • You are unlikely to be able to attend follow-up appointments after the procedure — for example, if your life expectancy is less than one year or if attending appointments regularly would be very difficult for you
  • Tests done before the procedure have revealed another serious illness, such as liver or kidney failure or an active infection
  • You are currently pregnant or breastfeeding

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8613962989292

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Affiliated Hospital of Nantong University
Registry
ClinicalTrials.gov
Start date
21 April 2025
Est. completion
1 June 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Treatment success at one year

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov